Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19001265 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Safety of Lymph Node Injection for Allergen Immunotherapy
Condition: Allergic Rhinitis
Interventions: Biological: Grass pollen extract;   Other: Placebo injection
2 Recruiting Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis
Condition: Allergic Rhinitis
Intervention: Biological: Allergen extract
3 Completed A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy
Condition: Rhinoconjunctivitis Due to Grass Pollen Allergy
Intervention: Biological: Allergen specific immunotherapy
4 Recruiting Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
Condition: Allergic Rhinitis
Interventions: Drug: HollisterStier;   Drug: Normal saline

Indicates status has not been verified in more than two years